Susquehanna International Group, LLP Galmed Pharmaceuticals Ltd. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$0.44 - $1.77 $3,036 - $12,213	-6,900 Reduced 35.57%	12,500 $9,000
Q1 2022 May 16, 2022	SELL	$1.23 - $2.07 $6,273 - $10,557	-5,100 Reduced 20.82%	19,400 $31,000
Q4 2021 Feb 14, 2022	SELL	$1.75 - $3.03 $6,650 - $11,514	-3,800 Reduced 13.43%	24,500 $45,000
Q3 2021 Nov 15, 2021	BUY	$2.41 - $3.33 $37,596 - $51,948	15,600 Added 122.83%	28,300 $79,000
Q2 2021 Aug 11, 2021	BUY	$2.24 - $3.9 $28,448 - $49,530	12,700 New	12,700 $39,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $153M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.